Short Interest in Pulmatrix, Inc. (NASDAQ:PULM) Drops By 85.8%

by · The Markets Daily

Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 58,600 shares, a decline of 85.8% from the November 15th total of 411,600 shares. Based on an average daily trading volume, of 446,600 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.6% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Pulmatrix in a report on Wednesday, December 4th. They issued a “hold” rating for the company.

View Our Latest Report on PULM

Pulmatrix Trading Down 0.8 %

Shares of PULM traded down $0.05 on Wednesday, reaching $5.91. 38,432 shares of the company’s stock were exchanged, compared to its average volume of 132,170. Pulmatrix has a 12 month low of $1.55 and a 12 month high of $8.44. The stock has a market capitalization of $21.57 million, a P/E ratio of -2.23 and a beta of 1.53. The business has a 50 day moving average price of $3.66 and a two-hundred day moving average price of $2.62.

About Pulmatrix

(Get Free Report)

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Featured Stories